L-CYSTEINE

L-CYSTEINE was reported 24 times

L-CYSTEINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEPATIC INFILTRATION EOSINOPHILIC 1 0.0164
1 PRODUCT COMPOUNDING QUALITY ISSUE 1 0.0027
2 GLYCOSURIA 3 0.0022
3 NASAL DISCHARGE DISCOLOURATION 2 0.0014
4 OTITIS MEDIA ACUTE 1 0.0014
5 HYPOGLYCAEMIA NEONATAL 1 0.0006
6 HEPATIC NEOPLASM MALIGNANT 1 0.0005
7 PNEUMOCYSTIS JIROVECI PNEUMONIA 1 0.0004
8 ANIMAL BITE 1 0.0004
9 POLYURIA 3 0.0004
10 LIVER ABSCESS 1 0.0003
11 CARDIAC FAILURE CHRONIC 1 0.0002
12 TENSION HEADACHE 1 0.0002
13 COLITIS MICROSCOPIC 1 0.0002
14 SPUTUM DISCOLOURED 2 0.0002
15 BODY TEMPERATURE DECREASED 2 0.0002
16 EAR DISCOMFORT 2 0.0002
17 ANORECTAL DISCOMFORT 1 0.0002
18 CHOLANGITIS 1 0.0002
19 POOR QUALITY DRUG ADMINISTERED 1 0.0002
20 APHONIA 2 0.0001
21 ARTHROPOD BITE 1 0.0001
22 BLOOD ALBUMIN DECREASED 1 0.0001
23 METASTASES TO LIVER 2 0.0001
24 RECALLED PRODUCT ADMINISTERED 1 0.0001
25 NEUTROPHIL COUNT INCREASED 1 0.0001
26 HEART RATE IRREGULAR 2 0.0001
27 NEOPLASM 1 0.0001
28 HYPOKALAEMIA 4 0.0001
29 NOCTURIA 1 0.0001
30 ABSCESS 1 0.0001
31 IMPAIRED HEALING 2 0.0001
32 BLOOD UREA INCREASED 1 0.0001
33 SCAR 1 0.0001
34 SYRINGE ISSUE 1 0.0001
35 HEART RATE DECREASED 2 0.0001
36 LYMPHOCYTE COUNT DECREASED 1 0.0001
37 INJECTION SITE MASS 2 0.0001
38 HEPATIC CIRRHOSIS 1 0.0001
39 DYSPNOEA EXERTIONAL 2 0.0001
40 THROAT IRRITATION 2 0.0000
41 SKIN DISCOLOURATION 2 0.0000
42 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
43 PRODUCTIVE COUGH 2 0.0000
44 HYPOGLYCAEMIA 2 0.0000
45 HEPATITIS 1 0.0000
46 GASTRITIS 1 0.0000
47 LABORATORY TEST ABNORMAL 1 0.0000
48 DYSPEPSIA 3 0.0000
49 FUNGAL INFECTION 1 0.0000
50 NEOPLASM PROGRESSION 1 0.0000
51 ACCIDENTAL OVERDOSE 1 0.0000
52 HEPATIC FUNCTION ABNORMAL 1 0.0000
53 EPISTAXIS 2 0.0000
54 HOT FLUSH 2 0.0000
55 ACNE 2 0.0000
56 LIVER DISORDER 1 0.0000
57 CARDIAC DISORDER 2 0.0000
58 SWELLING 2 0.0000
59 HEART RATE INCREASED 2 0.0000
60 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
61 SINUSITIS 2 0.0000
62 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
63 OEDEMA 1 0.0000
64 HERPES ZOSTER 1 0.0000
65 PALPITATIONS 2 0.0000
66 MUSCLE SPASMS 3 0.0000
67 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
68 VISUAL IMPAIRMENT 2 0.0000
69 GAIT DISTURBANCE 3 0.0000
70 INJECTION SITE REACTION 1 0.0000
71 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
72 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
73 BLOOD PRESSURE INCREASED 2 0.0000
74 TOXICITY TO VARIOUS AGENTS 2 0.0000
75 MYALGIA 2 0.0000
76 DRUG WITHDRAWAL SYNDROME 1 0.0000
77 INSOMNIA 3 0.0000
78 TACHYCARDIA 1 0.0000
79 NO ADVERSE EVENT 2 0.0000
80 NASOPHARYNGITIS 2 0.0000
81 SYNCOPE 1 0.0000
82 SOMNOLENCE 2 0.0000
83 CONDITION AGGRAVATED 3 0.0000
84 HYPERTENSION 2 0.0000
85 PLATELET COUNT DECREASED 1 0.0000
86 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
87 DIZZINESS 4 0.0000
88 ASTHENIA 3 0.0000
89 PRODUCT QUALITY ISSUE 1 0.0000
90 NEUTROPENIA 1 0.0000
91 MEMORY IMPAIRMENT 1 0.0000
92 COUGH 2 0.0000
93 ANXIETY 2 0.0000
94 INFECTION 1 0.0000
95 MALAISE 3 0.0000
96 INJECTION SITE PAIN 2 0.0000
97 PERIPHERAL SWELLING 1 0.0000
98 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
99 FATIGUE 4 0.0000
100 HYPOTENSION 1 0.0000
101 ERYTHEMA 1 0.0000
102 CONSTIPATION 1 0.0000
103 WEIGHT INCREASED 1 0.0000
104 DECREASED APPETITE 1 0.0000
105 FEELING ABNORMAL 1 0.0000
106 NAUSEA 3 0.0000
107 WEIGHT DECREASED 1 0.0000
108 HEADACHE 2 0.0000
109 DIARRHOEA 2 0.0000
110 PNEUMONIA 1 0.0000
111 PYREXIA 1 0.0000
112 PRURITUS 1 0.0000
113 ARTHRALGIA 1 0.0000
114 DYSPNOEA 1 0.0000
115 PAIN 1 0.0000
116 DEATH 1 0.0000